Matthew Taylor
Stock Analyst at Jefferies
(4.39)
# 1,215
Out of 4,534 analysts
662
Total ratings
54.4%
Success rate
6.9%
Average return
Main Sectors:
Stocks Rated by Matthew Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GEHC GE HealthCare Technologies | Maintained: Buy | $90 | $62.83 | +43.24% | 12 | Jul 13, 2026 | |
| RMD ResMed | Maintained: Hold | $245 → $225 | $198.61 | +13.29% | 16 | Jul 10, 2026 | |
| BSX Boston Scientific | Rated: Buy | $100 → $67 | $43.77 | +53.07% | 51 | Jun 24, 2026 | |
| SYK Stryker | Maintained: Buy | $465 → $455 | $319.14 | +42.57% | 35 | Jun 18, 2026 | |
| EW Edwards Lifesciences | Maintained: Buy | $102 | $85.00 | +20.00% | 68 | May 27, 2026 | |
| MDT Medtronic | Rated: Hold | $95 | $83.29 | +14.06% | 40 | Apr 24, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $145 → $135 | $101.66 | +32.80% | 42 | Apr 17, 2026 | |
| LNTH Lantheus Holdings | Reiterated: Buy | $105 → $110 | $104.40 | +5.36% | 13 | Mar 18, 2026 | |
| PODD Insulet | Reiterated: Buy | $400 | $167.37 | +138.99% | 30 | Feb 19, 2026 | |
| DXCM DexCom | Reiterated: Buy | $112 | $75.69 | +47.97% | 36 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $22.07 | -13.91% | 34 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $115 | $76.01 | +51.30% | 30 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $18.10 | +165.19% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 → $12 | $10.62 | +12.99% | 3 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $20.99 | -9.48% | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $130 → $110 | $89.72 | +22.60% | 28 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $79 → $80 | $79.21 | +1.00% | 13 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $61 → $63 | $93.42 | -32.56% | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $17.12 | +63.55% | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $4.43 | n/a | 4 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $353.17 | n/a | 24 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $305 → $255 | $154.48 | n/a | 29 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $215 → $145 | $134.03 | n/a | 32 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33.00 → $34.50 | $14.82 | n/a | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $16 → $15 | $15.36 | n/a | 23 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.5 → $6 | $5.11 | n/a | 3 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $18.89 | n/a | 16 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $105 | $43.45 | n/a | 1 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $14 | $3.71 | n/a | 1 | Jan 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 364.00 → CHF 255.00 | CHF 205.20 | n/a | 13 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $230 | $318.01 | n/a | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $5.5 | $6.69 | n/a | 2 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $179.45 | n/a | 2 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €49.00 | €23.66 | n/a | 21 | Jan 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $35.35 | n/a | 1 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $1.5 → $1 | $7.55 | n/a | 9 | Mar 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $16 | $13.71 | n/a | 2 | Jul 19, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $2.5 | $0.000001 | n/a | 2 | May 12, 2016 |
GE HealthCare Technologies
Jul 13, 2026
Maintained: Buy
Price Target: $90
Current: $62.83
Upside: +43.24%
ResMed
Jul 10, 2026
Maintained: Hold
Price Target: $245 → $225
Current: $198.61
Upside: +13.29%
Boston Scientific
Jun 24, 2026
Rated: Buy
Price Target: $100 → $67
Current: $43.77
Upside: +53.07%
Stryker
Jun 18, 2026
Maintained: Buy
Price Target: $465 → $455
Current: $319.14
Upside: +42.57%
Edwards Lifesciences
May 27, 2026
Maintained: Buy
Price Target: $102
Current: $85.00
Upside: +20.00%
Medtronic
Apr 24, 2026
Rated: Hold
Price Target: $95
Current: $83.29
Upside: +14.06%
Abbott Laboratories
Apr 17, 2026
Reiterated: Buy
Price Target: $145 → $135
Current: $101.66
Upside: +32.80%
Lantheus Holdings
Mar 18, 2026
Reiterated: Buy
Price Target: $105 → $110
Current: $104.40
Upside: +5.36%
Insulet
Feb 19, 2026
Reiterated: Buy
Price Target: $400
Current: $167.37
Upside: +138.99%
DexCom
Feb 13, 2026
Reiterated: Buy
Price Target: $112
Current: $75.69
Upside: +47.97%
Feb 12, 2026
Reiterated: Hold
Price Target: $19
Current: $22.07
Upside: -13.91%
Jan 8, 2026
Reiterated: Buy
Price Target: $105 → $115
Current: $76.01
Upside: +51.30%
Nov 7, 2025
Reiterated: Buy
Price Target: $48
Current: $18.10
Upside: +165.19%
Oct 3, 2025
Maintained: Hold
Price Target: $15 → $12
Current: $10.62
Upside: +12.99%
Aug 25, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $20.99
Upside: -9.48%
Aug 7, 2025
Maintained: Hold
Price Target: $130 → $110
Current: $89.72
Upside: +22.60%
Aug 7, 2025
Maintained: Buy
Price Target: $79 → $80
Current: $79.21
Upside: +1.00%
Aug 7, 2025
Maintained: Buy
Price Target: $61 → $63
Current: $93.42
Upside: -32.56%
Aug 5, 2025
Maintained: Buy
Price Target: $28
Current: $17.12
Upside: +63.55%
Jun 4, 2025
Maintained: Buy
Price Target: $18
Current: $4.43
Upside: n/a
May 2, 2025
Maintained: Hold
Price Target: n/a
Current: $353.17
Upside: n/a
May 1, 2025
Maintained: Buy
Price Target: $305 → $255
Current: $154.48
Upside: n/a
May 1, 2025
Reiterated: Hold
Price Target: $215 → $145
Current: $134.03
Upside: n/a
Apr 28, 2025
Maintained: Buy
Price Target: $33.00 → $34.50
Current: $14.82
Upside: n/a
Apr 14, 2025
Upgraded: Buy
Price Target: $16 → $15
Current: $15.36
Upside: n/a
Mar 4, 2025
Reiterated: Sell
Price Target: $0.5 → $6
Current: $5.11
Upside: n/a
Jul 16, 2024
Reiterated: Buy
Price Target: $50 → $48
Current: $18.89
Upside: n/a
Feb 1, 2024
Maintained: Hold
Price Target: $105
Current: $43.45
Upside: n/a
Jan 19, 2024
Initiated Coverage: Buy
Price Target: $14
Current: $3.71
Upside: n/a
Oct 28, 2022
Maintained: Hold
Price Target: CHF 364.00 → CHF 255.00
Current: CHF 205.20
Upside: n/a
Oct 12, 2022
Initiated Coverage: Buy
Price Target: $230
Current: $318.01
Upside: n/a
Mar 1, 2022
Maintained: Hold
Price Target: $7 → $5.5
Current: $6.69
Upside: n/a
Feb 7, 2022
Upgraded: Buy
Price Target: n/a
Current: $179.45
Upside: n/a
Jan 25, 2022
Maintained: Buy
Price Target: €49.00
Current: €23.66
Upside: n/a
Dec 6, 2019
Maintained: Hold
Price Target: n/a
Current: $35.35
Upside: n/a
Mar 8, 2018
Maintained: Sell
Price Target: $1.5 → $1
Current: $7.55
Upside: n/a
Jul 19, 2017
Maintained: Hold
Price Target: $17 → $16
Current: $13.71
Upside: n/a
May 12, 2016
Reiterated: Hold
Price Target: $5 → $2.5
Current: $0.000001
Upside: n/a